Recent developments in receptor tyrosine kinases targeted anticancer therapy

Novel concepts and understanding of receptors lead to discoveries and optimization of many small molecules and antibodies as anti-cancerous drugs. Receptor tyrosine kinases (RTKs) are such a promising class of receptors under the investigation in past three decades. RTKs are one of the essential med...

Descripción completa

Detalles Bibliográficos
Autores principales: Raval, Samir H., Singh, Ratn D., Joshi, Dilip V., Patel, Hitesh B., Mody, Shailesh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Veterinary World 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819356/
https://www.ncbi.nlm.nih.gov/pubmed/27051190
http://dx.doi.org/10.14202/vetworld.2016.80-90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819356/
https://www.ncbi.nlm.nih.gov/pubmed/27051190
http://dx.doi.org/10.14202/vetworld.2016.80-90

Ejemplares similares